Dividends Calendar Earnings Calendar
GOSS

GOSS | Gossamer Bio Inc

Gossamer Bio Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   California, United States

Trade prices

  • Volume:
  • Market Cap: 937M
  • Prev closed: 10.1
  • Open: 11.15
  • High: 11.61
  • Low: 10.36
  • 52 week low: 7.52
  • 52 week high: 26.35
  • Dividends:No Dividends

Next ER: November 9, 2021 



Top Stories (GOSS)

    Company Profile

    Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    November 16, 2021
    August 9, 2021-0.8 / -0.758- / -
    May 18, 2021- / -0.7675- / -
    May 6, 2021-0.78 / -0.756- / -
    February 25, 2021-0.88 / -0.79- / -
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Oct 11, 2021 13.390 12.650
    13.390
    12.640
    112.86K 6.52%
    Oct 8, 2021 12.570 12.430
    12.900
    12.360
    286.29K 1.95%
    Oct 7, 2021 12.330 12.410
    12.579
    12.170
    252.01K -0.24%
    Oct 6, 2021 12.360 12.050
    12.500
    11.810
    338.52K 1.15%
    Oct 5, 2021 12.220 12.470
    12.600
    12.070
    496.88K -2.32%
    Oct 4, 2021 12.510 12.930
    13.050
    12.440
    372.78K -4.14%
    Oct 1, 2021 13.050 12.560
    13.260
    12.374
    458.86K 3.82%
    Sep 30, 2021 12.570 13.230
    13.420
    12.430
    679.94K -4.41%
    Sep 29, 2021 13.150 13.230
    13.570
    12.960
    470.88K -0.6%
    Sep 28, 2021 13.230 12.790
    13.410
    12.630
    526.27K 2.40%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2015
    • Employees:118

    News

    News for (GOSS)

    This company doesn't provide a dividend.

    Key Persons

    • Chairman :  Chairperson: Faheem Hasnain
    • CEO :  Sheila Gujrathi M.D.
    • CFO :  Bryan Giraudo

    Talk about Gossamer Bio Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 9, 2021 (Same day)

    aap ash chk rok cah crbp dhi sanm lmnd ccep ceva jmia 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 100
    HOLD 0
    SELL 0

    Their Official Profiles 

    TwitterLinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Technical Analysis For Dummies
    Buy on Amazon

    Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.

    A simple, straightforward guide to the fundamentals of technical analysis